Management and CEO
This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Jennie Kardell
Interim-CEO, since 2024 / Chief Financial Officer, since 2023
Professional background
Jennie has broad financial skills and solid experience of accounting, process development, international establishment, IPOs and business combinations from a number of leading roles, including as interims CFO. She’s been a partner at Öresunds Redovisning AB for many years, where she the last two years led the integration following Ludvig & Co’s acquisition of the company in 2021 as Office Manager.
Education
Bachelor in Science in Business and Economics from Uppsala University and SRF Certified Accounting consultant.
Other assignments
CFO at Odinwell AB (publ.), Chairman of SRF Konsulterna, Södra Kretsen, board member of Fields of Gold AB.
Shares in Redsense Medical
6 107 shares
Sebastien Bollue
Chief Operating Officer, joined 2016
Professional background
Sebastien joined the company in 2016, first in the role as Commercial Operations Manager and later as Director of Commercial Operations. He is responsible for leading day-to-day commercial activities, but also coordinates distribution, marketing and clinical evaluations.
Education
Master in International Marketing from Halmstad University, Bachelor in International Business: Marketing and Sales from Haaga-Helia University.
Certifications in Supply Chain Strategy and Management (MIT Sloan School on Management). Clinical Evaluation & Post Market Surveillance (Medqure), Large Account Management Process and Strategic Selling with Perspective (Miller Heiman Group)
Other assignments
No other assignments
Shares in Redsense Medical
50 000 shares
Ann-Marie Eriksson
Chief Technical Officer, since 2020
Professional background
Ann-Marie joined Redsense Medical in January 2020 as new CTO. Her most recent position was at the Halmstad branch of Etteplan Sweden AB, where she led the team successfully as Department manager, area manager and teamleader. She has solid experience of project management and quality systems management, with particular expertise in medical devices.
Education
Master of Science in Electrical Engineering with specialization in signal processing and telecommunication from the Chalmers University of Technology.
Other assignments
Member of TK62 since 2020 Member of IEC MT20 since 2022.
Shares in Redsense Medical
2 407 shares and 30 000 warrants
Brendan Kane
U.S. Director of Sales, since 2016
Professional background
He has more than 30 years of renal industry experience, and his career has encompassed various sales, sales management, and business development positions, with National Medical Care, Fresenius Medical Care, American Renal Associated, innovating Health Specialists, and others.
Education
B.S.Stonehill College North Easton, MA
Other assignments
No other assignments
Shares in Redsense Medical
50 000 shares and 30 000 warrants
Jane Hurst
U.S. Clinical Director, since 2007
Professional background
Jane became a Registered Nurse in 1980. Her clinical experience includes nephrology, hemodialysis, burns, oncology, and work as a nurse educator. In 2002 she obtained a specialized nursing certification as a legal nurse consultant that enables her to consult for attorneys, insurance companies, businesses, and various authorities.
Education
Miami Valley Hospital Wright State University School of Nursing
Other assignments
Continue providing assistance and insight into medical-legal issues.
Shares in Redsense Medical
105 000 shares